.
Pharmacotherapy in Urology
Study Course Description
Course Description Statuss:Approved
Course Description Version:8.00
Study Course Accepted:21.03.2024 09:26:06
Study Course Information | |||||||||
Course Code: | KK_016 | LQF level: | Level 7 | ||||||
Credit Points: | 1.00 | ECTS: | 1.50 | ||||||
Branch of Science: | Clinical Medicine | Target Audience: | Clinical Pharmacy | ||||||
Study Course Supervisor | |||||||||
Course Supervisor: | Vilnis Lietuvietis | ||||||||
Study Course Implementer | |||||||||
Structural Unit: | Department of Surgery | ||||||||
The Head of Structural Unit: | |||||||||
Contacts: | Riga, Pilsoņu Street 13, VSIA P.Stradiņa KUS, 24th building, kkrsu[pnkts]lv, +371 67069745 | ||||||||
Study Course Planning | |||||||||
Full-Time - Semester No.1 | |||||||||
Lectures (count) | 4 | Lecture Length (academic hours) | 2 | Total Contact Hours of Lectures | 8 | ||||
Classes (count) | 2 | Class Length (academic hours) | 2 | Total Contact Hours of Classes | 4 | ||||
Total Contact Hours | 12 | ||||||||
Study course description | |||||||||
Preliminary Knowledge: | Basics of a human anathomy, physiology and pathology, microbiology, pharmacology and health care organisation. | ||||||||
Objective: | Aim of the cycle is to achieve basic understanding of the nature of urological diseases, clinical representation, diagnostic data interpretation, principles of pharmaceutical treatment and prophylaxis. | ||||||||
Topic Layout (Full-Time) | |||||||||
No. | Topic | Type of Implementation | Number | Venue | |||||
1 | Urological diseases diagnostic measurements, their interpretation. | Lectures | 1.00 | other | |||||
2 | Symptoms and syndromes in urology. Kidney stone disease. | Lectures | 1.00 | other | |||||
3 | Acute and chronic urinary tract infections. Prevention of urological diseases. | Lectures | 1.00 | other | |||||
4 | Benign prostatic hyperplasia, prostate cancer, kidney, bladder and Penile tumors. | Lectures | 1.00 | other | |||||
5 | Urological diseases diagnostic measurements, their interpretation. Conduction of drug treatment plan. | Classes | 1.00 | other | |||||
6 | Chronic urinary tract disease diagnostic measurment evaluation and conduction and adjustments of drug treatment plan. | Classes | 1.00 | other | |||||
Assessment | |||||||||
Unaided Work: | The student independently uses the literature suggested in the study course, creates a summary of the information obtained. Prepares clinical pharmacist's assessment of drug therapy cases. | ||||||||
Assessment Criteria: | Active participation in day to day duties. Homework is submitted on time and in good quality. Quality of oral answers provided. Exam: knowledge acquired in the study course (including the analysis of drug therapy) is valued. The final result consists of 50% case presentation during classes and 50% examination results. | ||||||||
Final Examination (Full-Time): | Exam | ||||||||
Final Examination (Part-Time): | |||||||||
Learning Outcomes | |||||||||
Knowledge: | On successful completion of the course student will gain knowledge that will allow to understand: • the etiology of urological disease, pathogenesis, prevention; • the clinical picture of the disease and its complications; • modern clinical, laboratory and instrumental methods of patient investigation results; • and analyse the pharmaceutical methods of treatment, their selection criteria. | ||||||||
Skills: | On successful completion of the course student will be able to: • understand and analyse the urological patients according to the findings of the investigation; • interpret laboratory and instrumental methods of investigation data; • understand the clinical diagnosis and together with a doctor student will be able to create a drug treatment plan and follow its results; • monitor drug therapy of a chronic urological patients and identify if adjustments or extra evaluation is needed; • inform patients about urological disease prevention abilities. | ||||||||
Competencies: | On completion of the study course students will be able to: • identify individual urologic patient medical treatment plan in collaboration with health professionals; • evaluate drug treatment advantages and disadvantages, linking them to the patient's examination data; • monitor the progress of drug therapy, evaluate the results and prepare the necessary information for other medical professionals. | ||||||||
Bibliography | |||||||||
No. | Reference | ||||||||
Required Reading | |||||||||
1 | Lekciju materiāls/ Lecture materials | ||||||||
2 | Oxford Handbook of Urology. 4th Edition. John Reynard, Simon Brewster and Suzanne Biers, 816 pages. 2019 | ||||||||
3 | Evidence-based Urology. Philipp Dahm (Editor), Roger Dmochowski (Editor). 2018, BMJ Books | ||||||||
Additional Reading | |||||||||
1 | Campbell-Walsh Urology. Alan J. Wein (Hon), Louis R. Kavoussi, Andrew C. Novick, Alan W. Partin, Craig A. Peters. Saunders, 2018 | ||||||||
2 | The Cancer Handbook. Ed. by Malcolm R.Alison - 2th ed. - Wiley, 2007. | ||||||||
3 | Baltiņa D., Baltiņš M., Doniņa S. Klīniskā onkoloģija. - Rīga: Zvaigzne, 1999. | ||||||||
4 | Urogenital Infections, Edited by Kurt G. Naber, Anthony J. Schaeffer et al.2010 | ||||||||
5 | EAU Guidelines, edition presented at the 25th EAU Annual Congress, Barcelona 2010. | ||||||||
Other Information Sources | |||||||||
1 | RSU un Latvijas Medicīnas bibliotēkas resursi/ RSU library resources |